vs
RCM TECHNOLOGIES, INC.（RCMT）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RCM TECHNOLOGIES, INC.的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$86.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 7.1%，领先377.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 12.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 9.6%）
埃克塞拉科技是一家美国业务流程自动化企业，由SourceHOV、Novitex Holdings与Quinpario Acquisition Corp. 2合并组建，专注为各行业客户提供自动化业务解决方案，助力企业优化运营流程、提升运转效率。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
RCMT vs RIGL — 直观对比
营收规模更大
RCMT
是对方的1.2倍
$69.8M
营收增速更快
RIGL
高出8.8%
12.4%
净利率更高
RIGL
高出377.0%
7.1%
两年增速更快
RIGL
近两年复合增速
9.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $86.5M | $69.8M |
| 净利润 | $6.1M | $268.1M |
| 毛利率 | 28.1% | 91.5% |
| 营业利润率 | 9.2% | 33.2% |
| 净利率 | 7.1% | 384.0% |
| 营收同比 | 12.4% | 21.2% |
| 净利润同比 | 112.9% | 1769.2% |
| 每股收益（稀释后） | $0.80 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RCMTRIGL
| Q1 26 | $86.5M | — | ||
| Q4 25 | — | $69.8M | ||
| Q3 25 | $70.3M | $69.5M | ||
| Q2 25 | $78.2M | $101.7M | ||
| Q1 25 | $84.5M | $53.3M | ||
| Q4 24 | $76.9M | $57.6M | ||
| Q3 24 | $60.4M | $55.3M | ||
| Q2 24 | $69.2M | $36.8M |
净利润RCMTRIGL
| Q1 26 | $6.1M | — | ||
| Q4 25 | — | $268.1M | ||
| Q3 25 | $2.3M | $27.9M | ||
| Q2 25 | $3.8M | $59.6M | ||
| Q1 25 | $4.2M | $11.4M | ||
| Q4 24 | $2.9M | $14.3M | ||
| Q3 24 | $2.7M | $12.4M | ||
| Q2 24 | $3.8M | $-1.0M |
毛利率RCMTRIGL
| Q1 26 | 28.1% | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | 27.6% | 93.2% | ||
| Q2 25 | 28.5% | 95.6% | ||
| Q1 25 | 26.0% | 91.7% | ||
| Q4 24 | 28.0% | 89.9% | ||
| Q3 24 | 29.6% | 85.5% | ||
| Q2 24 | 28.9% | 92.4% |
营业利润率RCMTRIGL
| Q1 26 | 9.2% | — | ||
| Q4 25 | — | 33.2% | ||
| Q3 25 | 5.6% | 40.9% | ||
| Q2 25 | 8.4% | 60.1% | ||
| Q1 25 | 7.8% | 23.9% | ||
| Q4 24 | 8.2% | 28.9% | ||
| Q3 24 | 7.3% | 25.4% | ||
| Q2 24 | 8.4% | 1.2% |
净利率RCMTRIGL
| Q1 26 | 7.1% | — | ||
| Q4 25 | — | 384.0% | ||
| Q3 25 | 3.2% | 40.2% | ||
| Q2 25 | 4.8% | 58.6% | ||
| Q1 25 | 5.0% | 21.5% | ||
| Q4 24 | 3.7% | 24.9% | ||
| Q3 24 | 4.5% | 22.5% | ||
| Q2 24 | 5.4% | -2.8% |
每股收益（稀释后）RCMTRIGL
| Q1 26 | $0.80 | — | ||
| Q4 25 | — | $14.11 | ||
| Q3 25 | $0.30 | $1.46 | ||
| Q2 25 | $0.50 | $3.28 | ||
| Q1 25 | $0.54 | $0.63 | ||
| Q4 24 | $0.38 | $0.82 | ||
| Q3 24 | $0.35 | $0.70 | ||
| Q2 24 | $0.47 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.9M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $46.0M | $391.5M |
| 总资产 | $134.4M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资RCMTRIGL
| Q1 26 | $2.9M | — | ||
| Q4 25 | — | $155.0M | ||
| Q3 25 | $1.3M | $137.1M | ||
| Q2 25 | $5.5M | $108.4M | ||
| Q1 25 | $5.2M | $77.1M | ||
| Q4 24 | $4.7M | $77.3M | ||
| Q3 24 | $3.2M | $61.1M | ||
| Q2 24 | $3.5M | $49.1M |
总债务RCMTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益RCMTRIGL
| Q1 26 | $46.0M | — | ||
| Q4 25 | — | $391.5M | ||
| Q3 25 | $41.4M | $117.6M | ||
| Q2 25 | $37.8M | $81.9M | ||
| Q1 25 | $34.6M | $18.6M | ||
| Q4 24 | $33.5M | $3.3M | ||
| Q3 24 | $30.0M | $-14.6M | ||
| Q2 24 | $28.5M | $-29.9M |
总资产RCMTRIGL
| Q1 26 | $134.4M | — | ||
| Q4 25 | — | $513.6M | ||
| Q3 25 | $129.8M | $242.5M | ||
| Q2 25 | $135.6M | $206.7M | ||
| Q1 25 | $121.0M | $176.0M | ||
| Q4 24 | $132.1M | $164.0M | ||
| Q3 24 | $125.5M | $139.4M | ||
| Q2 24 | $118.3M | $128.4M |
负债/权益比RCMTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.11× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流RCMTRIGL
| Q1 26 | $19.0M | — | ||
| Q4 25 | — | $22.0M | ||
| Q3 25 | $-1.3M | $24.0M | ||
| Q2 25 | $-7.9M | $30.5M | ||
| Q1 25 | $16.7M | $-893.0K | ||
| Q4 24 | $-1.6M | $14.5M | ||
| Q3 24 | $-4.3M | $21.7M | ||
| Q2 24 | $5.7M | $302.0K |
自由现金流RCMTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $-1.8M | — | ||
| Q2 25 | $-8.4M | — | ||
| Q1 25 | $16.2M | — | ||
| Q4 24 | $-2.6M | — | ||
| Q3 24 | $-4.9M | — | ||
| Q2 24 | $5.3M | — |
自由现金流率RCMTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -2.5% | — | ||
| Q2 25 | -10.7% | — | ||
| Q1 25 | 19.2% | — | ||
| Q4 24 | -3.4% | — | ||
| Q3 24 | -8.1% | — | ||
| Q2 24 | 7.7% | — |
资本支出强度RCMTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.6% | — |
现金转化率RCMTRIGL
| Q1 26 | 3.11× | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | -0.56× | 0.86× | ||
| Q2 25 | -2.08× | 0.51× | ||
| Q1 25 | 3.98× | -0.08× | ||
| Q4 24 | -0.57× | 1.01× | ||
| Q3 24 | -1.58× | 1.75× | ||
| Q2 24 | 1.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
